Label: SODIUM BICARBONATE ANTACID- sodium bicarbonate tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated January 10, 2025

If you are a consumer or patient please visit this version.

  • Drug Facts

    Active ingredient (in each tablet)

    Sodium bicarbonate 10 gr (650 mg)

  • Purpose

    Antacid

  • Uses

    relieves:

    • acid indigestion
    • heartburn
    • sour stomach
    • upset stomach associated with these symptoms
  • Warnings

    Do not takemore than 24 tablets for adults up to 60 years of age (or 12 tablets for adults 60 yeasr of age and older) in a 24-hour period nor use the maximum dosage for more than 2 weeks, except under the advice and supervision of a physician.

    Ask a doctor before use if you havea sodium restricted diet.

    Ask a doctor or pharmacist before use if you aretaking a prescription drug.

    Antacids may interact with certain prescription drugs.

    Stop use and ask a doctor ifsymptoms last more than 2 weeks

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children.

    In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

  • ​Directions

    • do not use the maximum dosage for more than 2 weeks
    • tablets may be swallowed whole or dissolved in water prior to use
    • adults 60 years of age and over:1-2 tablets every 4 hours, not more than 12 tablets in 24 hours
    • adults under 60 years of age:1-4 tablets every 4 hours, not more than 24 tablets in 24 hours
  • Other information

    • each tablet contains: sodium 178 mg
    • store at room temperature 15º - 30º C (59º - 86º F)
  • Inactive ingredients

    croscarmellose sodium, microcrystalline cellulose, silica, stearic acid and talc

  • Questions or comments?

    1-800-645-2158

  • SPL UNCLASSIFIED SECTION

    TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

    Distributed by:

    Rugby Laboratories

    17177 N Laurel Park Drive, Suite 233

    Livonia, MI 48152

    www.rugbylaboratories.com

    Rev. 12/16 R-29

  • Repackaging Information

    Please reference the How Suppliedsection listed above for a description of individual tablets. This drug product has been received by Aphena Pharma - TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:

    Count650 mg
    6071610-669-53
    9071610-669-60
    18071610-669-80

    Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.

    Repackaged by:
    Aphena Pharma Solutions - TN
    Cookeville, TN 38506

    20221018JK

  • PRINCIPAL DISPLAY PANEL - 650 mg

    NDC 71610-669 - Sodium Bicarbonate 650 mg Tablets
    Bottle Label 650 mg

  • INGREDIENTS AND APPEARANCE
    SODIUM BICARBONATE ANTACID 
    sodium bicarbonate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71610-669(NDC:0536-1047)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) (SODIUM CATION - UNII:LYR4M0NH37) SODIUM BICARBONATE650 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    TALC (UNII: 7SEV7J4R1U)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize11mm
    FlavorImprint Code CPC77
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71610-669-5360 in 1 BOTTLE; Type 0: Not a Combination Product10/18/2022
    2NDC:71610-669-6090 in 1 BOTTLE; Type 0: Not a Combination Product10/18/2022
    3NDC:71610-669-80180 in 1 BOTTLE; Type 0: Not a Combination Product10/18/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00103/25/2015
    Labeler - Aphena Pharma Solutions - Tennessee, LLC (128385585)
    Establishment
    NameAddressID/FEIBusiness Operations
    Aphena Pharma Solutions - Tennessee, LLC128385585repack(71610-669)